PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 68 filers reported holding PARATEK PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,130,000 | +16.4% | 73,378 | -1.7% | 0.00% | 0.0% |
| Q3 2016 | $971,000 | +29.0% | 74,653 | +37.9% | 0.00% | 0.0% |
| Q2 2016 | $753,000 | +15.5% | 54,133 | +25.9% | 0.00% | 0.0% |
| Q1 2016 | $652,000 | -17.8% | 42,998 | +2.9% | 0.00% | 0.0% |
| Q4 2015 | $793,000 | +0.4% | 41,787 | +0.5% | 0.00% | 0.0% |
| Q3 2015 | $790,000 | -27.7% | 41,564 | -1.9% | 0.00% | 0.0% |
| Q2 2015 | $1,092,000 | +15500.0% | 42,385 | +19522.7% | 0.00% | – |
| Q1 2015 | $7,000 | -12.5% | 216 | 0.0% | 0.00% | – |
| Q4 2014 | $8,000 | – | 216 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,600,410 | $36,172,000 | 26.83% |
| Abingworth LLP | 1,301,413 | $18,103,000 | 18.96% |
| Roumell Asset Management, LLC | 290,136 | $4,036,000 | 9.16% |
| Monashee Investment Management LLC | 100,000 | $1,391,000 | 2.19% |
| BVF INC/IL | 575,000 | $7,998,000 | 1.70% |
| Aisling Capital LLC | 482,680 | $6,714,000 | 1.59% |
| Opaleye Management Inc. | 146,700 | $2,041,000 | 1.36% |
| Broadfin Capital, LLC | 803,332 | $11,174,000 | 1.09% |
| GENERAL AMERICAN INVESTORS CO INC | 477,076 | $6,636,000 | 0.69% |
| Opus Point Partners Management, LLC | 37,665 | $524,000 | 0.51% |